title: Different La/SS-B mRNA isoforms are expressed in salivary gland tissue of patients with primary Sjögren's syndrome.
abstract: Recently we isolated a La/SS-B mRNA isoform from a cDNA library made from peripheral blood lymphocytes of a patient with primary Sjögren's Syndrome. In the La/SS-B mRNA isoform the exon 1 was replaced. The alternative exon was termed exon 1'. Genomic analysis showed that the exon 1' La mRNA was the result of a promoter-switch in combination with alternative splicing. Due to the unusual structure of the exon 1' La/SS-B mRNA, the function and the behaviour under physiological and pathophysiological conditions in tissue of patients with primary Sjögren's syndrome or Systemic Lupus Erythematosus remained obscure. Therefore assays were established allowing a qualitative and quantitative estimation of expression of the exon 1 and 1' La mRNA form, including in situ and dot blot hybridization as well as reversed PCR. Both mRNA forms were found to represent finally processed cytoplasmic mRNAs belonging to the abundant class of mRNAs. They were expressed and regulated in parallel. A ratio exon 1 to 1' between 1:1 and 5:1 was determined. Both mRNA forms were downregulated in quiescent cells and upregulated in activated and proliferating cells including non-keratized stratified squamous epithelial, endothelial, salivary gland as well as infiltrating cells.
authors.affiliation: Institut für Physiologische Chemie, Johannes-Gutenberg Universität, Mainz, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Bachmann
authors.forename: M
authors.initials: M
authors.lastname: Hilker
authors.forename: D
authors.initials: D
authors.lastname: Grölz
authors.forename: G
authors.initials: G
authors.lastname: Tellmann
authors.forename: U
authors.initials: U
authors.lastname: Hake
authors.forename: L
authors.initials: L
authors.lastname: Kater
authors.forename: P
authors.initials: P
authors.lastname: de Wilde
authors.forename: H
authors.initials: H
authors.lastname: Tröster
mesh_terms: D001324:Autoantigens / Q000235:genetics*; D001483:Base Sequence; D003593:Cytoplasm / Q000378:metabolism; D017931:DNA Primers / Q000235:genetics; D018076:DNA, Complementary / Q000235:genetics; D004730:Endothelium, Vascular / Q000276:immunology / Q000378:metabolism; D004848:Epithelium / Q000276:immunology / Q000378:metabolism; D005091:Exons; D015870:Gene Expression; D006801:Humans; D017403:In Situ Hybridization; D008969:Molecular Sequence Data; D009154:Mutation; D016133:Polymerase Chain Reaction; D012323:RNA Processing, Post-Transcriptional; D012333:RNA, Messenger / Q000235:genetics* / Q000378:metabolism*; D012261:Ribonucleoproteins / Q000235:genetics*; D012469:Salivary Glands / Q000098:blood supply / Q000276:immunology* / Q000378:metabolism*; D012859:Sjogren's Syndrome / Q000235:genetics* / Q000276:immunology* / Q000378:metabolism; D000097585:SS-B Antigen
chemical_list: D001324:Autoantigens; D017931:DNA Primers; D018076:DNA, Complementary; D012333:RNA, Messenger; D012261:Ribonucleoproteins; D000097585:SS-B Antigen